Stay updated on Baricitinib in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Adult Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
- Check51 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check59 days agoChange DetectedEli Lilly and Company has added a new resource regarding a study on Baricitinib for treating moderate to severe atopic dermatitis.SummaryDifference0.4%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check73 days agoChange DetectedThe website has been updated to include a new type of intervention in version 2.14.0, while the previous version 2.13.3 has removed the type of intervention and a study link related to Baricitinib for atopic dermatitis.SummaryDifference0.5%
Stay in the know with updates to Baricitinib in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.